Cargando…

Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a cancer that is sensitive to ferroptosis, and immunotherapy has emerged as a promising treatment for HCC patients. However, the prognostic potential of ferroptosis-related genes (FRGs) and the effect of ferroptosis on the tumor immune microenvironment in HCC remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bo, Zhao, Jilong, Liu, Bing, Shang, Yanan, Chen, Fei, Zhang, Sidi, He, Jiayao, Fan, Yumei, Tan, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280137/ https://www.ncbi.nlm.nih.gov/pubmed/35847985 http://dx.doi.org/10.3389/fmolb.2022.940575

Ejemplares similares

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2022)

Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
por: Ye, Ying, et al.
Publicado: (2021)

Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity
por: Chen, Fei, et al.
Publicado: (2022)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy
por: Xu, Jing, et al.
Publicado: (2022)

Erratum: A metabolism- associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023)

Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma
por: Zhang, Shiyu, et al.
Publicado: (2023)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2021)

Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022)

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8(+) T Cell Infiltration
por: Zou, Yiping, et al.
Publicado: (2021)

Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma
por: Liu, Dong-Li, et al.
Publicado: (2022)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Frontiers Production Office,
Publicado: (2022)

A Glycolysis-Related Gene Signature Correlates With the Characteristics of the Tumor Immune Microenvironment and Predicts Prognosis in Patients With Hepatocellular Carcinoma
por: Yang, Jun, et al.
Publicado: (2022)

Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma
por: Wang, Wenjuan, et al.
Publicado: (2022)

Prediction of Prognosis in Patients With Endometrial Carcinoma and Immune Microenvironment Estimation Based on Ferroptosis-Related Genes
por: Liu, Shouze, et al.
Publicado: (2022)

Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2023)

A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021)

Therapeutic Implications of Ferroptosis in Renal Fibrosis
por: Zhang, Yao, et al.
Publicado: (2022)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors
por: Han, Songtao, et al.
Publicado: (2023)

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
por: Liu, Lixia, et al.
Publicado: (2021)

Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jsfce82in2kbpravho6pft5v0q